Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AXGT Axovant Gene Therapies Ltd

0.00 (0.00%)
May 16 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 2.09
Ask Price 2.11
News -
Company Name Stock Ticker Symbol Market Type
Axovant Gene Therapies Ltd AXGT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 2.10 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.10 2.10
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 2.10 USD

Axovant Gene Therapies Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 99.22M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Axovant Gene Therapies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AXGT Message Board. Create One! See More Posts on AXGT Message Board See More Message Board Posts

Historical AXGT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Axovant Gene Therapies Description

Axovant Gene Therapies Ltd is a clinical-stage company that is focused on gene therapy for neurodegenerative diseases. The company is developing its pipeline for the treatment of debilitating diseases, including Parkinson's disease, GM1 gangliosidosis, and GM2 gangliosidosis. It currently has three clinical-stage programs which include AXO-Lenti-PD program for Parkinson's disease, AXO-AAV-GM1 program for GM1 gangliosidosis, and AXO-AAV-GM1 program for GM2 gangliosidosis (including Tay-Sachs and Sandhoff diseases).

Your Recent History

Delayed Upgrade Clock